*Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult with a physician before using this or any dietary supplement
Both compounds share the same regulatory timeline: moved to Category 2 in 2023, removed from Category 2 in April 2026, and scheduled for PCAC review on July 23, 2026
Tirzepatide Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist
Drugs such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are widely used in type 2 diabetes and obesity management
Noom now explicitly sells a Microdose GLP-1 Rx Program, using Rebel Wilson as their spokesperson
Always store both unopened and reconstituted vials in their original dark containers or in a dark, protected environment to preserve their integrity